Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890779030> ?p ?o ?g. }
- W2890779030 endingPage "1561" @default.
- W2890779030 startingPage "1515" @default.
- W2890779030 abstract "The neurokinins are indisputably essential neurotransmitters in numerous pathoand physiological events. Being widely distributed in the Central Nervous System (CNS) and peripheral tissues, their discovery rapidly promoted them to drugs targets. As a necessity for molecular tools to understand the biological role of this class, endogenous peptides and their receptors prompted the scientific community to design ligands displaying either agonist and antagonist activity at the three main neurokinin receptors, called NK1, NK2 and NK3. Several strategies were implemented for this purpose. With a preference to small non-peptidic ligands, many research groups invested efforts in synthesizing and evaluating a wide range of scaffolds, but only the NK1 antagonist Aprepitant (EMENDT) and its prodrug Fosaprepitant (IVEMENDT) have been approved by the Food Drug Administration (FDA) for the treatment of Chemotherapy-Induced and Post-Operative Nausea and Vomiting (CINV and PONV, respectively). While non-peptidic drugs showed limitations, especially in side effect control, peptidic and pseudopeptidic compounds progressively regained attention. Various strategies were implemented to modulate affinity, selectivity and activity of the newly designed ligands. Replacement of canonical amino acids, incorporation of conformational constraints, and fusion with non-peptidic moieties gave rise to families of ligands displaying individual or dual NK1, NK2 and NK3 antagonism, that ultimately were combined with non-neurokinin ligands (such as opioids) to target enhanced biological impact." @default.
- W2890779030 created "2018-09-27" @default.
- W2890779030 creator A5002859621 @default.
- W2890779030 creator A5016228824 @default.
- W2890779030 date "2020-03-27" @default.
- W2890779030 modified "2023-09-26" @default.
- W2890779030 title "The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications" @default.
- W2890779030 cites W1491269320 @default.
- W2890779030 cites W1529329394 @default.
- W2890779030 cites W1542803245 @default.
- W2890779030 cites W1577289413 @default.
- W2890779030 cites W1578565140 @default.
- W2890779030 cites W1578783190 @default.
- W2890779030 cites W1586542845 @default.
- W2890779030 cites W1594437720 @default.
- W2890779030 cites W1599368877 @default.
- W2890779030 cites W1601917353 @default.
- W2890779030 cites W1868930382 @default.
- W2890779030 cites W1909556211 @default.
- W2890779030 cites W1934561697 @default.
- W2890779030 cites W1963585743 @default.
- W2890779030 cites W1964431575 @default.
- W2890779030 cites W1964942415 @default.
- W2890779030 cites W1965035457 @default.
- W2890779030 cites W1966580470 @default.
- W2890779030 cites W1966949725 @default.
- W2890779030 cites W1967590627 @default.
- W2890779030 cites W1967594561 @default.
- W2890779030 cites W1967866503 @default.
- W2890779030 cites W1967883762 @default.
- W2890779030 cites W1967927763 @default.
- W2890779030 cites W1970817117 @default.
- W2890779030 cites W1971205041 @default.
- W2890779030 cites W1974202057 @default.
- W2890779030 cites W1974486357 @default.
- W2890779030 cites W1977474883 @default.
- W2890779030 cites W1977498600 @default.
- W2890779030 cites W1978321775 @default.
- W2890779030 cites W1979324277 @default.
- W2890779030 cites W1979951815 @default.
- W2890779030 cites W1981018090 @default.
- W2890779030 cites W1981489308 @default.
- W2890779030 cites W1982969289 @default.
- W2890779030 cites W1983413945 @default.
- W2890779030 cites W1983792284 @default.
- W2890779030 cites W1984030173 @default.
- W2890779030 cites W1984547809 @default.
- W2890779030 cites W1985982649 @default.
- W2890779030 cites W1986232549 @default.
- W2890779030 cites W1987526028 @default.
- W2890779030 cites W1988011068 @default.
- W2890779030 cites W1988097700 @default.
- W2890779030 cites W1988194899 @default.
- W2890779030 cites W1988502836 @default.
- W2890779030 cites W1992947383 @default.
- W2890779030 cites W1992960817 @default.
- W2890779030 cites W1992961161 @default.
- W2890779030 cites W1993960188 @default.
- W2890779030 cites W1994372270 @default.
- W2890779030 cites W1995591781 @default.
- W2890779030 cites W1995814282 @default.
- W2890779030 cites W1997139032 @default.
- W2890779030 cites W1997414602 @default.
- W2890779030 cites W1998067652 @default.
- W2890779030 cites W1998829740 @default.
- W2890779030 cites W2000735865 @default.
- W2890779030 cites W2001097589 @default.
- W2890779030 cites W2001391701 @default.
- W2890779030 cites W2002526993 @default.
- W2890779030 cites W2003441248 @default.
- W2890779030 cites W2003665363 @default.
- W2890779030 cites W2004094930 @default.
- W2890779030 cites W2004381214 @default.
- W2890779030 cites W2005358668 @default.
- W2890779030 cites W2005568660 @default.
- W2890779030 cites W2007565764 @default.
- W2890779030 cites W2008494508 @default.
- W2890779030 cites W2009084539 @default.
- W2890779030 cites W2010096250 @default.
- W2890779030 cites W2010158585 @default.
- W2890779030 cites W2010516521 @default.
- W2890779030 cites W2010841889 @default.
- W2890779030 cites W2011447602 @default.
- W2890779030 cites W2011963145 @default.
- W2890779030 cites W2012126452 @default.
- W2890779030 cites W2015800743 @default.
- W2890779030 cites W2015948082 @default.
- W2890779030 cites W2015989065 @default.
- W2890779030 cites W2016911622 @default.
- W2890779030 cites W2017248048 @default.
- W2890779030 cites W2017787550 @default.
- W2890779030 cites W2018683380 @default.
- W2890779030 cites W2019247959 @default.
- W2890779030 cites W2019975952 @default.
- W2890779030 cites W2020039948 @default.
- W2890779030 cites W2023714955 @default.
- W2890779030 cites W2023726854 @default.
- W2890779030 cites W2025052248 @default.